Search for: "State v. Holman" Results 41 - 60 of 143
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Apr 2022, 5:58 am
Mr Justice Holman ordered a temporary stay of the consent order.It will be noted that the wife played no part in the above drama. [read post]
31 Jan 2013, 7:50 am by Kali Borkoski
In this case, respondent Myriad Genetics holds a patent on two genes, mutations in which are correlated with a higher risk of breast or ovarian cancer, in their “isolated” state. [read post]
11 Nov 2022, 9:40 am by Holman
by Chris Holman As reported in posts by Dennis and Jason, the Supreme Court recently granted certiorari in Amgen v. [read post]
30 Jan 2008, 5:42 am
LG Electronics (Chris Holman-UMKC School of Law), Stoneridge Investment v. [read post]
31 Jan 2020, 3:36 am by Edith Roberts
At The Atlantic, Garrett Epps looks at the story behind a state constitutional provision relied on by Montana in Espinoza v. [read post]
11 Feb 2011, 3:27 am by Adam Wagner
Mr Justice Holman ruled that the decision was unlawful on two grounds: namely, that the secretary of stated failed to consult the councils adequately in respect of the effect on individual schools, and that he failed to discharge his duties to carry out an equalities impact assessment. [read post]
26 Aug 2009, 6:12 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Nexavar (Sorafenib) – India: Delhi High Court rejects Bayer complaint for patent linkage (Intellectual Property Watch) (Spicy IP) (GenericsWeb) Evista / Xigris - US: CAFC grants en banc request to challenge written description requirement: Ariad v Lilly (Patently-O) (Filewrapper) (Washington State Patent Law Blog)… [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen… [read post]